Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 229 | 233 | PF00656 | 0.450 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.419 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.635 |
CLV_NRD_NRD_1 | 99 | 101 | PF00675 | 0.489 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.635 |
CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.506 |
CLV_PCSK_SKI1_1 | 112 | 116 | PF00082 | 0.375 |
CLV_PCSK_SKI1_1 | 180 | 184 | PF00082 | 0.193 |
CLV_PCSK_SKI1_1 | 99 | 103 | PF00082 | 0.511 |
DOC_CDC14_PxL_1 | 271 | 279 | PF14671 | 0.447 |
DOC_CYCLIN_RxL_1 | 63 | 76 | PF00134 | 0.434 |
DOC_MAPK_gen_1 | 154 | 163 | PF00069 | 0.462 |
DOC_MAPK_gen_1 | 67 | 74 | PF00069 | 0.592 |
DOC_MAPK_MEF2A_6 | 170 | 178 | PF00069 | 0.288 |
DOC_MAPK_MEF2A_6 | 67 | 74 | PF00069 | 0.533 |
DOC_MAPK_NFAT4_5 | 67 | 75 | PF00069 | 0.526 |
DOC_PP1_RVXF_1 | 152 | 158 | PF00149 | 0.357 |
DOC_PP4_FxxP_1 | 5 | 8 | PF00568 | 0.475 |
DOC_USP7_MATH_1 | 94 | 98 | PF00917 | 0.596 |
DOC_WW_Pin1_4 | 112 | 117 | PF00397 | 0.453 |
DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.450 |
DOC_WW_Pin1_4 | 261 | 266 | PF00397 | 0.410 |
DOC_WW_Pin1_4 | 74 | 79 | PF00397 | 0.423 |
LIG_14-3-3_CanoR_1 | 156 | 161 | PF00244 | 0.508 |
LIG_14-3-3_CanoR_1 | 52 | 61 | PF00244 | 0.457 |
LIG_14-3-3_CanoR_1 | 67 | 71 | PF00244 | 0.588 |
LIG_14-3-3_CanoR_1 | 99 | 108 | PF00244 | 0.636 |
LIG_Clathr_ClatBox_1 | 33 | 37 | PF01394 | 0.354 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.389 |
LIG_FHA_2 | 113 | 119 | PF00498 | 0.426 |
LIG_FHA_2 | 181 | 187 | PF00498 | 0.523 |
LIG_FHA_2 | 217 | 223 | PF00498 | 0.468 |
LIG_FHA_2 | 241 | 247 | PF00498 | 0.536 |
LIG_IRF3_LxIS_1 | 198 | 203 | PF10401 | 0.393 |
LIG_LIR_Apic_2 | 104 | 110 | PF02991 | 0.469 |
LIG_LIR_Apic_2 | 3 | 8 | PF02991 | 0.474 |
LIG_LIR_Gen_1 | 197 | 207 | PF02991 | 0.450 |
LIG_LIR_Gen_1 | 227 | 234 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 159 | 163 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 197 | 202 | PF02991 | 0.450 |
LIG_LIR_Nem_3 | 227 | 231 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 59 | 64 | PF02991 | 0.449 |
LIG_MYND_1 | 275 | 279 | PF01753 | 0.508 |
LIG_SH2_NCK_1 | 228 | 232 | PF00017 | 0.509 |
LIG_SH2_PTP2 | 42 | 45 | PF00017 | 0.376 |
LIG_SH2_STAP1 | 90 | 94 | PF00017 | 0.457 |
LIG_SH2_STAT5 | 199 | 202 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 239 | 242 | PF00017 | 0.362 |
LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.376 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.455 |
LIG_TRAF2_1 | 233 | 236 | PF00917 | 0.455 |
LIG_TYR_ITIM | 40 | 45 | PF00017 | 0.370 |
LIG_WRC_WIRS_1 | 157 | 162 | PF05994 | 0.435 |
LIG_WRC_WIRS_1 | 202 | 207 | PF05994 | 0.450 |
MOD_CDC14_SPxK_1 | 264 | 267 | PF00782 | 0.402 |
MOD_CDK_SPxK_1 | 261 | 267 | PF00069 | 0.412 |
MOD_CK1_1 | 125 | 131 | PF00069 | 0.446 |
MOD_CK1_1 | 56 | 62 | PF00069 | 0.483 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.368 |
MOD_CK2_1 | 180 | 186 | PF00069 | 0.450 |
MOD_CK2_1 | 240 | 246 | PF00069 | 0.537 |
MOD_CK2_1 | 85 | 91 | PF00069 | 0.571 |
MOD_DYRK1A_RPxSP_1 | 112 | 116 | PF00069 | 0.418 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.521 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.436 |
MOD_GlcNHglycan | 293 | 297 | PF01048 | 0.478 |
MOD_GlcNHglycan | 48 | 51 | PF01048 | 0.393 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.524 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.416 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.476 |
MOD_GSK3_1 | 201 | 208 | PF00069 | 0.419 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.481 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.488 |
MOD_N-GLC_1 | 194 | 199 | PF02516 | 0.250 |
MOD_NEK2_1 | 101 | 106 | PF00069 | 0.476 |
MOD_NEK2_1 | 200 | 205 | PF00069 | 0.493 |
MOD_NEK2_1 | 28 | 33 | PF00069 | 0.363 |
MOD_NEK2_1 | 66 | 71 | PF00069 | 0.596 |
MOD_NEK2_1 | 81 | 86 | PF00069 | 0.414 |
MOD_NEK2_2 | 201 | 206 | PF00069 | 0.521 |
MOD_PIKK_1 | 101 | 107 | PF00454 | 0.412 |
MOD_PIKK_1 | 12 | 18 | PF00454 | 0.467 |
MOD_PIKK_1 | 85 | 91 | PF00454 | 0.556 |
MOD_PKA_1 | 99 | 105 | PF00069 | 0.423 |
MOD_PKA_2 | 66 | 72 | PF00069 | 0.586 |
MOD_PKA_2 | 99 | 105 | PF00069 | 0.496 |
MOD_PKB_1 | 154 | 162 | PF00069 | 0.430 |
MOD_Plk_1 | 180 | 186 | PF00069 | 0.450 |
MOD_Plk_1 | 226 | 232 | PF00069 | 0.458 |
MOD_Plk_2-3 | 216 | 222 | PF00069 | 0.509 |
MOD_Plk_4 | 125 | 131 | PF00069 | 0.423 |
MOD_Plk_4 | 156 | 162 | PF00069 | 0.433 |
MOD_Plk_4 | 29 | 35 | PF00069 | 0.343 |
MOD_ProDKin_1 | 112 | 118 | PF00069 | 0.449 |
MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.450 |
MOD_ProDKin_1 | 261 | 267 | PF00069 | 0.412 |
MOD_ProDKin_1 | 74 | 80 | PF00069 | 0.420 |
MOD_SUMO_rev_2 | 204 | 214 | PF00179 | 0.477 |
MOD_SUMO_rev_2 | 215 | 220 | PF00179 | 0.452 |
TRG_DiLeu_BaEn_1 | 236 | 241 | PF01217 | 0.517 |
TRG_ENDOCYTIC_2 | 199 | 202 | PF00928 | 0.450 |
TRG_ENDOCYTIC_2 | 228 | 231 | PF00928 | 0.509 |
TRG_ENDOCYTIC_2 | 266 | 269 | PF00928 | 0.424 |
TRG_ENDOCYTIC_2 | 294 | 297 | PF00928 | 0.448 |
TRG_ENDOCYTIC_2 | 42 | 45 | PF00928 | 0.376 |
TRG_ER_diArg_1 | 153 | 156 | PF00400 | 0.330 |
TRG_ER_diArg_1 | 66 | 68 | PF00400 | 0.576 |
TRG_ER_diArg_1 | 99 | 101 | PF00400 | 0.440 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4IST6 | Bodo saltans | 47% | 100% |
A0A1X0NY44 | Trypanosomatidae | 65% | 100% |
A0A3R7MC48 | Trypanosoma rangeli | 67% | 100% |
A0A3S7WZF0 | Leishmania donovani | 90% | 100% |
A4I1R5 | Leishmania infantum | 90% | 100% |
C9ZKC1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 68% | 100% |
E9AXV0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4Q9M1 | Leishmania major | 90% | 100% |